Close

Piper Jaffray Would Buy Deciphera Pharmaceuticals (DCPH) Into ESMO

September 4, 2018 7:31 AM EDT Send to a Friend
Piper Jaffray analyst, Christopher Raymond, reiterated his Overweight rating on shares of Deciphera (NASDAQ: DCPH) ahead of a key ESMO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login